Previous Article | Next Article ![]()
Infect. Immun., 05 1996, 1762-1769, Vol 64, No. 5
R Landmann, HP Knopf, S Link, S Sansano, R Schumann and W Zimmerli
Membrane CD14 is involved in lipopolysaccharide (LPS)-induced monocyte
activation; it binds LPS, and antibodies against CD14 block the effects of
low-dose LPS. It is unknown how LPS regulates its own receptor CD14 in
vitro. Therefore, we investigated the effects of LPS on CD14 mRNA and
membrane and soluble CD14 (mCD14 and sCD14, respectively) in human
monocytes and macrophages. No changes were observed during the first 3 h of
LPS stimulation. After 6 to 15 h, LPS weakly reduced CD14 mRNA and mCD14
and transiently enhanced sCD14 release. A 2-day incubation with LPS caused
increases in the levels of CD14 mRNA (2-fold), mCD14 (2- fold), sCD14
(1.5-fold), and LPS-fluorescein isothiocyanate binding (1.5-fold); a 5-h
incubation with LPS was sufficient to induce the late effects on mCD14 and
sCD14. The maximal effect on mCD14 and sCD14 was reached with > or = 1
ng of LPS per ml; the proportional distribution of the two sCD14 isoforms
was not modified by LPS. Besides rough and smooth LPS, lipid A, heat-killed
Escherichia coli, lipoteichoic acid, and Staphylococcus aureus cell wall
extract (10 micrograms/ml) caused similar increases of mCD14. The LPS
effect was blocked by polymyxin B but not by anti-tumor necrosis factor
alpha, anti-interleukin-6, anti- gamma interferon, and anti-LPS-binding
protein. LPS-induced tumor necrosis factor alpha production was abolished
after a second 4-h challenge. In contrast, the LPS-induced increases CD14
mRNA, mCD14, and sCD14 were stronger and appeared earlier after a second
LPS challenge. In conclusion, CD14 is transcriptionally upregulated by LPS
and other bacterial cell wall constituents.
Copyright © 1996, American Society for Microbiology
Human monocyte CD14 is upregulated by lipopolysaccharide
Department of Research and Internal Medicine, University Hospital, Basel, Switzerland.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|